Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

  1. Iacoboni, G.
  2. Rejeski, K.
  3. Villacampa, G.
  4. van Doesum, J.A.
  5. Chiappella, A.
  6. Bonifazi, F.
  7. Lopez-Corral, L.
  8. van Aalderen, M.
  9. Kwon, M.
  10. Martınez-Cibrian, N.
  11. Bramanti, S.
  12. Reguera-Ortega, J.L.
  13. Camacho-Arteaga, L.
  14. Schmidt, C.
  15. Marın-Niebla, A.
  16. Kersten, M.J.
  17. Garcia-Sancho, A.M.
  18. Zinzani, P.L.
  19. Corradini, P.
  20. van Meerten, T.
  21. Subklewe, M.
  22. Barba, P.
Revue:
Blood Advances

ISSN: 2473-9537,  2473-9529

Année de publication: 2022

Volumen: 6

Número: 12

Pages: 3606-3610

Type: Lettre

DOI: 10.1182/BLOODADVANCES.2021006922 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus